 Long-term effect mexiletine left ventricular function relation suppression ventricular arrhythmia effects oral mexiletine left ventricular LV ejection fraction EF ventricular arrhythmias possible relation effects months therapy patients chronic ventricular premature complexes VPCs normal LVEF Holter monitoring radionuclide ventriculography rest maximum tolerable exercise testing average titration period days mean daily mexiletine dose mg treatment end titration months treatment patients baseline LVEF equal group median reduction hourly VPC rate baseline LVEF group Couplets runs ventricular tachycardia patients single patient proarrhythmic increase VPCs treatment baseline significant changes exercise LVEF months treatment groups patients correlation treatment-induced changes arrhythmia frequency EF symptoms congestive heart failure study long-term use mexiletine efficacious free cardiac depressant effects patients diminished LV function